Personalized Medicine Biomarkers Global Market Report 2025
상품코드:1751070
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
맞춤형 의료 바이오마커 시장 규모는 향후 몇 년간 빠르게 성장할 것으로 예상됩니다. 2024년 228억 5천만 달러에서 2025년 269억 8천만 달러로 연평균 성장률(CAGR) 18.0%로 성장할 것으로 예상됩니다. 예측 기간 동안 이러한 성장은 정밀 종양학 분야에서 바이오마커의 적용 확대, 표적 치료에 대한 수요 증가, 질병의 조기 발견에 대한 주목 증가, 개인화 접근에 대한 소비자 수요 증가, 정부의 지원 정책과 자금 제공에 의한 것으로 예측됩니다. 예측 기간에 예상되는 주요 동향에는 바이오마커 식별에 있어서의 멀티오믹스 어프로치의 채용, 리퀴드 바이옵시에 근거한 바이오마커의 개발, 디지털 바이오마커의 이용의 확대, 바이오마커 탐색에 있어서의 AI와 머신러닝의 통합 등 바이오마커 검증에 있어서의 실제 증거의 확대 등이 있습니다.
만성 질환의 유병률 증가는 개인화된 의료 바이오마커 시장의 상당한 성장을 가속할 것으로 예측됩니다. 만성 질환 증가는 건강에 해로운 라이프 스타일 선택, 식생활 교란, 운동 부족, 높은 스트레스 수준이 주요 원인입니다. 개인 맞춤형 의료 바이오마커는 개인의 유전적 및 분자적 프로필에 따라 치료를 맞춤화하여 이러한 상태를 관리하는 데 중요한 역할을 합니다. 이 바이오 마커는 가장 효과적인 치료법을 확인하고 질병의 진행을 예측하고 부작용을 최소화하는 데 도움이 됩니다. 보건기구(WHO)는 2050년까지 새로운 암 환자 수가 3,500만명을 넘어설 것으로 예측하고 있으며, 2022년 대비 77% 증가할 것으로 예측했습니다.
맞춤형 의료 바이오 마커 시장의 기업은 제품의 신뢰성을 높이고 시장 범위를 확대하고 환자의 결과를 개선하기 위해 규제 당국의 승인 취득에 주력하고 있습니다. Illumina Inc.는 암 바이오마커 검사와 2개의 동반진단제에 대해 FDA의 승인을 취득했습니다. 이 테스트는 차세대 시퀀싱(NGS) 기술을 사용하여 암세포의 유전자 돌연변이를 식별하여 임상의가 개별 바이오마커를 기반으로 가장 적합한 치료법을 선택할 수 있도록 합니다. 이번 승인은 프리시전 종양에 있어서의 중요한 이정표이며, 치료 선택의 스피드와 정밀도를 향상시켜, 암 환자에 대한 맞춤형 치료를 강화하는 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 태와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 맞춤형 의료 바이오마커 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 맞춤형 의료 바이오마커 시장 : 성장률 분석
세계의 맞춤형 의료 바이오마커 시장 실적: 규모와 성장, 2019년-2024년
세계의 맞춤형 의료 바이오마커 시장 예측 : 규모와 성장, 2024년-2029년, 2034년
세계의 맞춤형 의료 바이오마커 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 맞춤형 의료 바이오마커 시장 : 바이오마커 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
유전체
단백질체학
대사
기타 바이오마커의 유형
세계의 맞춤형 의료 바이오마커 시장 : 질환 적응증별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
종양학
신경학
당뇨병
자가면역질환
심장병학
기타 적응증
세계의 맞춤형 의료 바이오마커 시장 : 용도별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
조기 발견 또는 스크리닝
진단
치료의 선택
모니터링
세계의 맞춤형 의료 바이오마커 시장 : 최종 용도별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
병원 및 진료소
제약 및 생명 공학 기업
진단 실험실
기타 최종 사용자
세계의 맞춤형 의료 바이오마커 시장 :유전체별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
일염기 다형(SNP)
카피수 변이(CNV)
유전자 발현 바이오마커
후성 유전 바이오 마커
세계의 맞춤형 의료 바이오마커 시장 : 단백질체학유형별 세분화, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
단백질 발현 바이오마커
번역후 수식(PTM) 바이오마커
단백질간 상호작용 바이오마커
효소 활성 바이오마커
세계의 맞춤형 의료 바이오마커 시장 : 대사별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
지질 바이오마커
아미노산 바이오마커
탄수화물 바이오마커
호르몬 바이오마커
세계의 맞춤형 의료 바이오마커 시장 : 기타 바이오마커 유형 세분화(유형별), 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
염증 바이오마커
마이크로바이옴 바이오마커
자가항체 바이오마커
세포외 소포 바이오마커
제7장 지역별/국가별 분석
세계의 맞춤형 의료 바이오마커 시장 :지역별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
세계의 맞춤형 의료 바이오마커 시장 : 국가별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
맞춤형 의료 바이오 마커 시장 : 경쟁 구도
맞춤형 의료 바이오 마커 시장 : 기업 프로파일
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Merck KGaA
GE Healthcare
Laboratory Corporation of America Holdings(LabCorp)
Agilent Technologies Inc.
Hologic Inc.
Illumina Inc.
PerkinElmer Inc.
Beckman Coulter Inc.
Bio-Rad Laboratories Inc.
QIAGEN NV
DH Life Sciences LLC
Myriad Genetics Inc.
Guardant Health Inc.
Cardiff Oncology Inc.
23andMe Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
맞춤형 의료 바이오마커 시장 2029년 : 새로운 기회를 제공하는 국가
맞춤형 의료 바이오마커 시장 2029년 : 새로운 기회를 제공하는 부문
맞춤형 의료 바이오마커 시장 2029년 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Personalized medicine biomarkers are specific biological indicators that customize medical treatments for individual patients based on their unique genetic, molecular, or physiological characteristics. These biomarkers help predict how a patient will respond to a particular drug, allowing healthcare providers to select the most effective and safest treatment options.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main types of biomarkers in personalized medicine include genomic, proteomic, metabolic, and other types. Genomic biomarkers refer to specific genes or genetic mutations that provide insights into how diseases develop and progress in individuals. These biomarkers are used for a variety of disease indications, such as oncology, neurology, diabetes, autoimmune diseases, cardiology, and more. They serve various purposes, including early detection or screening, diagnosis, treatment selection, and monitoring. Personalized medicine biomarkers are utilized by a range of end users, including hospitals and clinics, pharmaceutical and biotechnology companies, diagnostic laboratories, and others.
The personalized medicine biomarkers market research report is one of a series of new reports from The Business Research Company that provides personalized medicine biomarkers market statistics, including personalized medicine biomarkers industry global market size, regional shares, competitors with a personalized medicine biomarkers market share, detailed personalized medicine biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the personalized medicine biomarkers industry. This personalized medicine biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The personalized medicine biomarkers market size has grown rapidly in recent years. It will grow from $22.85 billion in 2024 to $26.98 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases, the rising adoption of companion diagnostics, growing investment in biomarker research, a heightened focus on early diagnosis and preventive healthcare, and regulatory support for biomarker-based therapies.
The personalized medicine biomarkers market size is expected to see rapid growth in the next few years. It will grow to $51.53 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth during the forecast period can be attributed to the expanding applications of biomarkers in precision oncology, rising demand for targeted therapies, a growing focus on early disease detection, increasing consumer demand for personalized approaches, and supportive government policies and funding. Key trends expected in the forecast period include the adoption of a multi-omics approach for biomarker identification, the development of liquid biopsy-based biomarkers, a growing use of digital biomarkers, the integration of AI and machine learning in biomarker discovery, and the expansion of real-world evidence in biomarker validation.
The growing prevalence of chronic diseases is expected to drive substantial growth in the personalized medicine biomarkers market. Chronic diseases are long-term conditions that develop gradually and persist for extended periods, often requiring ongoing medical care or affecting daily activities. The rise in chronic diseases is largely attributed to unhealthy lifestyle choices, poor diets, insufficient physical activity, and high stress levels. Personalized medicine biomarkers play a key role in managing these conditions by tailoring treatments based on individual genetic and molecular profiles. These biomarkers help identify the most effective therapies, predict disease progression, and minimize adverse effects. For example, the World Health Organization (WHO) predicts that by 2050, the number of new cancer cases will exceed 35 million, a 77% increase from 2022. This escalating prevalence of chronic diseases is accelerating demand for personalized medicine biomarkers.
Companies in the personalized medicine biomarkers market are focusing on obtaining regulatory approvals to enhance product credibility, expand their market reach, and improve patient outcomes. Regulatory approvals are essential as they ensure that medical products, treatments, or technologies meet safety, efficacy, and quality standards. For instance, in August 2024, Illumina, Inc., a US-based biotechnology company, received FDA approval for its cancer biomarker test and two companion diagnostics. The test uses next-generation sequencing (NGS) technology to identify genetic mutations in cancer cells, allowing clinicians to select the most appropriate treatments based on individual biomarkers. This approval represents a significant milestone in precision oncology, improving the speed and accuracy of treatment selection and enhancing personalized care for cancer patients.
In February 2025, Renovaro Inc., a US-based biotechnology firm, merged with BioSymetrics Inc. to boost AI-driven biomarker discovery and precision medicine initiatives. The merger is set to enhance drug development and facilitate the creation of personalized treatment strategies, particularly for complex diseases. BioSymetrics Inc., a Canada-based company specializing in phenomics-driven drug discovery, uses machine learning to integrate clinical and experimental data, advancing the field of precision medicine.
Major players in the personalized medicine biomarkers market are AbbVie Inc., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Merck KGaA, GE Healthcare, Laboratory Corporation of America Holdings (LabCorp), Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., DH Life Sciences LLC, Myriad Genetics Inc., Guardant Health Inc., Cardiff Oncology Inc., 23andMe Inc., Coriell Life Sciences Inc.
North America was the largest region in the personalized medicine biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in personalized medicine biomarkers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the personalized medicine biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The personalized medicine biomarkers market consists of sales of biomarker-based diagnostic kits, reagents, testing platforms, epigenetic biomarkers, companion diagnostics, predictive biomarkers, prognostic biomarkers, and multi-omics biomarkers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Personalized Medicine Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on personalized medicine biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for personalized medicine biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The personalized medicine biomarkers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Biomarker Type: Genomic; Proteomics; Metabolic; Other Biomarker Types
2) By Disease Indication: Oncology; Neurology; Diabetes; Autoimmune Diseases; Cardiology; Other Indications
3) By Application: Early Detection Or Screening; Diagnosis; Treatment Selection; Monitoring
4) By End Use: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Diagnostic Labs; Other End Users
Subsegments:
1) By Genomic: Single Nucleotide Polymorphisms (SNPs); Copy Number Variations (CNVs); Gene Expression Biomarkers; Epigenetic Biomarkers
2) By Proteomics: Protein Expression Biomarkers; Post-Translational Modification (PTM) Biomarkers; Protein-Protein Interaction Biomarkers; Enzyme Activity Biomarkers
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Personalized Medicine Biomarkers Market Characteristics
3. Personalized Medicine Biomarkers Market Trends And Strategies
4. Personalized Medicine Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Personalized Medicine Biomarkers Growth Analysis And Strategic Analysis Framework
5.1. Global Personalized Medicine Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Personalized Medicine Biomarkers Market Growth Rate Analysis
5.4. Global Personalized Medicine Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Personalized Medicine Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Personalized Medicine Biomarkers Total Addressable Market (TAM)
6. Personalized Medicine Biomarkers Market Segmentation
6.1. Global Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genomic
Proteomics
Metabolic
Other Biomarker Types
6.2. Global Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Neurology
Diabetes
Autoimmune Diseases
Cardiology
Other Indications
6.3. Global Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Early Detection Or Screening
Diagnosis
Treatment Selection
Monitoring
6.4. Global Personalized Medicine Biomarkers Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Pharmaceutical And Biotechnology Companies
Diagnostic Labs
Other End Users
6.5. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Genomic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Nucleotide Polymorphisms (SNPs)
Copy Number Variations (CNVs)
Gene Expression Biomarkers
Epigenetic Biomarkers
6.6. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Protein Expression Biomarkers
Post-Translational Modification (PTM) Biomarkers
Protein-Protein Interaction Biomarkers
Enzyme Activity Biomarkers
6.7. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Metabolic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lipid Biomarkers
Amino Acid Biomarkers
Carbohydrate Biomarkers
Hormone Biomarkers
6.8. Global Personalized Medicine Biomarkers Market, Sub-Segmentation Of Other Biomarker Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inflammatory Biomarkers
Microbiome Biomarkers
Autoantibody Biomarkers
Extracellular Vesicle Biomarkers
7. Personalized Medicine Biomarkers Market Regional And Country Analysis
7.1. Global Personalized Medicine Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Personalized Medicine Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Personalized Medicine Biomarkers Market
8.1. Asia-Pacific Personalized Medicine Biomarkers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Personalized Medicine Biomarkers Market
9.1. China Personalized Medicine Biomarkers Market Overview
9.2. China Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Personalized Medicine Biomarkers Market
10.1. India Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Personalized Medicine Biomarkers Market
11.1. Japan Personalized Medicine Biomarkers Market Overview
11.2. Japan Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Personalized Medicine Biomarkers Market
12.1. Australia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Personalized Medicine Biomarkers Market
13.1. Indonesia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Personalized Medicine Biomarkers Market
14.1. South Korea Personalized Medicine Biomarkers Market Overview
14.2. South Korea Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Personalized Medicine Biomarkers Market
15.1. Western Europe Personalized Medicine Biomarkers Market Overview
15.2. Western Europe Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Personalized Medicine Biomarkers Market
16.1. UK Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Personalized Medicine Biomarkers Market
17.1. Germany Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Personalized Medicine Biomarkers Market
18.1. France Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Personalized Medicine Biomarkers Market
19.1. Italy Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Personalized Medicine Biomarkers Market
20.1. Spain Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Personalized Medicine Biomarkers Market
21.1. Eastern Europe Personalized Medicine Biomarkers Market Overview
21.2. Eastern Europe Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Personalized Medicine Biomarkers Market
22.1. Russia Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Personalized Medicine Biomarkers Market
23.1. North America Personalized Medicine Biomarkers Market Overview
23.2. North America Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Personalized Medicine Biomarkers Market
24.1. USA Personalized Medicine Biomarkers Market Overview
24.2. USA Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Personalized Medicine Biomarkers Market
25.1. Canada Personalized Medicine Biomarkers Market Overview
25.2. Canada Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Personalized Medicine Biomarkers Market
26.1. South America Personalized Medicine Biomarkers Market Overview
26.2. South America Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Personalized Medicine Biomarkers Market
27.1. Brazil Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Personalized Medicine Biomarkers Market
28.1. Middle East Personalized Medicine Biomarkers Market Overview
28.2. Middle East Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Personalized Medicine Biomarkers Market
29.1. Africa Personalized Medicine Biomarkers Market Overview
29.2. Africa Personalized Medicine Biomarkers Market, Segmentation By Biomarker Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Personalized Medicine Biomarkers Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Personalized Medicine Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Personalized Medicine Biomarkers Market Competitive Landscape And Company Profiles
30.1. Personalized Medicine Biomarkers Market Competitive Landscape
30.2. Personalized Medicine Biomarkers Market Company Profiles
30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Personalized Medicine Biomarkers Market Other Major And Innovative Companies
31.1. Merck KGaA
31.2. GE Healthcare
31.3. Laboratory Corporation of America Holdings (LabCorp)
31.4. Agilent Technologies Inc.
31.5. Hologic Inc.
31.6. Illumina Inc.
31.7. PerkinElmer Inc.
31.8. Beckman Coulter Inc.
31.9. Bio-Rad Laboratories Inc.
31.10. QIAGEN N.V.
31.11. DH Life Sciences LLC
31.12. Myriad Genetics Inc.
31.13. Guardant Health Inc.
31.14. Cardiff Oncology Inc.
31.15. 23andMe Inc.
32. Global Personalized Medicine Biomarkers Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Personalized Medicine Biomarkers Market
34. Recent Developments In The Personalized Medicine Biomarkers Market
35. Personalized Medicine Biomarkers Market High Potential Countries, Segments and Strategies
35.1 Personalized Medicine Biomarkers Market In 2029 - Countries Offering Most New Opportunities
35.2 Personalized Medicine Biomarkers Market In 2029 - Segments Offering Most New Opportunities
35.3 Personalized Medicine Biomarkers Market In 2029 - Growth Strategies
